Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (111-120 of 403) with videos related to

Pageof 41
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 4, 2013
Sun protection training based on a theater play for preschoolers: an effective method for imparting knowledge on sun protection?Nadja Seidel, Friederike Stoelzel, Marlene Garzarolli, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2007
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomasFrank P Kroschinsky, Kai Friedrichsen, Juliane Mueller, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2003
Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatmentAlexander Kiani, Claus-Henning Köhne, Thorsten Franz, et al.
Plos One|April 23, 2014
Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8Irene Michalk, Anja Feldmann, Stefanie Koristka, et al.
Annals of Hematology|December 16, 2003
CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluidMartin Bornhauser, Andreas Jenke, Jens Freiberg-Richter, et al.
Journal of Cancer Research and Clinical Oncology|September 30, 2019
Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomasFrank Kroschinsky, Denise Röllig, Barbara Riemer, et al.
Haematologica|July 14, 2011
Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapseKatja Sockel, Martin Wermke, Jörgen Radke, et al.
Plos One|May 25, 2013
EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinomaAndreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, et al.
Plos One|June 1, 2011
Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donorsAlexander H Schmidt, Ute V Solloch, Daniel Baier, et al.
Human Immunology|August 18, 2009
Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planningAlexander H Schmidt, Daniel Baier, Ute V Solloch, et al.
Pageof 41

Showing results (111-120 of 403) with videos related to

Sort By:
Pageof 41
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 4, 2013
Sun protection training based on a theater play for preschoolers: an effective method for imparting knowledge on sun protection?Nadja Seidel, Friederike Stoelzel, Marlene Garzarolli, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2007
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomasFrank P Kroschinsky, Kai Friedrichsen, Juliane Mueller, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2003
Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatmentAlexander Kiani, Claus-Henning Köhne, Thorsten Franz, et al.
Plos One|April 23, 2014
Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8Irene Michalk, Anja Feldmann, Stefanie Koristka, et al.
Annals of Hematology|December 16, 2003
CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluidMartin Bornhauser, Andreas Jenke, Jens Freiberg-Richter, et al.
Journal of Cancer Research and Clinical Oncology|September 30, 2019
Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomasFrank Kroschinsky, Denise Röllig, Barbara Riemer, et al.
Haematologica|July 14, 2011
Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapseKatja Sockel, Martin Wermke, Jörgen Radke, et al.
Plos One|May 25, 2013
EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinomaAndreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, et al.
Plos One|June 1, 2011
Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donorsAlexander H Schmidt, Ute V Solloch, Daniel Baier, et al.
Human Immunology|August 18, 2009
Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planningAlexander H Schmidt, Daniel Baier, Ute V Solloch, et al.
Pageof 41